Last reviewed · How we verify

NCT06234189: TIDOCT

The Immediate Effect of Defocus Spectacles On the Choroid Thickness Using Optical Coherence Tomography on Children

Completed NA Last updated 25 June 2025
What this trial tests

NA trial testing Defocus Incorporated Multiple Segment Spectacle Lenses (DIMS) in Myopia in 16 participants. Completed in 7 March 2024.

Timeline
1 February 2024
Primary endpoint
7 March 2024
7 March 2024

Quick facts

Lead sponsorVejle Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment16
Start date1 February 2024
Primary completion7 March 2024
Estimated completion7 March 2024
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Vejle Hospital

Who can join

10 and older, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose is to examine temporary changes in the subfoveal choroid thickness after removal and after resumed use of Defocus Incorporated Multiple Segment Spectacle Lenses (DIMS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Vejle Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06234189.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing